Li Xiang-ju, Zhao Jun, Wang Ping, Wu Qi, Li Ji-you, Wang Jie, Li Xiang-hong
Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):400-4. doi: 10.3760/cma.j.issn.0529-5807.2012.06.009.
To study the cytopathologic features of transbronchial needle aspiration (TBNA) samples and to evaluate the role of cytopathology in the diagnosis and staging of lung carcinomas, as compared to histopathology.
Three hundred seventy-four cytology specimens were collected by TBNA using 21-gauge needle, including 65 lung masses and 309 lymph nodes. Direct smears and liquid-based thin-layer preparations were performed for each case. The correlation between cytology and histopathologic diagnoses were analyzed.
The sensitivity, specificity, false positive rate, false negative rate and accuracy of cytopathology in diagnosing lung carcinomas by TBNA was 95.7% (88/92) (266/278), 100% (96/96), 0 (0/96), 4.3% (12/278) and 96.8% (362/374), respectively. Overall 62.8% (167/266) of the cases were precisely typed, including 95.7% (88/92) of small cell carcinoma, 73.5% (25/34) of squamous cell carcinoma and 67.9% (53/78) of adenocarcinoma. There was no statistical difference in the diagnostic accuracy of cytopathology between lung mass aspiration and mediastinal lymph node aspiration, as well as between subcarinal lymph node aspiration and other lymph node aspiration (all P > 0.05). There was also no statistical difference in the diagnostic accuracy between direct smears and liquid-based preparations (χ(2) = 0.11, P > 0.05).
Cytopathology of TBNA specimens is accurate and sensitive for diagnosing pulmonary carcinomas. In most cases, the lung carcinoma can be precisely typed. TBNA is useful for diagnosing and staging lung carcinomas.
研究经支气管针吸活检(TBNA)样本的细胞病理学特征,并评估细胞病理学在肺癌诊断和分期中的作用,与组织病理学进行比较。
使用21号针通过TBNA收集374例细胞学标本,包括65个肺肿块和309个淋巴结。对每个病例进行直接涂片和液基薄层制片。分析细胞学与组织病理学诊断之间的相关性。
TBNA诊断肺癌时,细胞病理学的敏感性、特异性、假阳性率、假阴性率和准确率分别为95.7%(88/92)(266/278)、100%(96/96)、0(0/96)、4.3%(12/278)和96.8%(362/374)。总体而言,62.8%(167/266)的病例被准确分型,包括95.7%(88/92)的小细胞癌、73.5%(25/34)的鳞状细胞癌和67.9%(53/78)的腺癌。肺肿块穿刺活检与纵隔淋巴结穿刺活检之间、隆突下淋巴结穿刺活检与其他淋巴结穿刺活检之间,细胞病理学诊断准确性无统计学差异(均P>0.05)。直接涂片和液基制片之间的诊断准确性也无统计学差异(χ(2)=0.11,P>0.05)。
TBNA标本的细胞病理学对肺癌诊断准确且敏感。在大多数情况下,肺癌可被准确分型。TBNA对肺癌的诊断和分期有用。